Andere Sprachen SD BioSensor, Inc

Aktien

A137310

KR7137310009

A137310

Schlusskurs Korea S.E. Andere Börsenplätze 00:00:00 07.06.2024			% 5 Tage	% 1. Jan.
9.960 ^KRW	+0,40 %		0,00 %	-12,94 %

29.01.	MÄRKTE ASIEN/Freundlich - Schanghai schwächer	DJ
29.01.	MÄRKTE ASIEN/Freundlich - Schanghai schwächer	DJ

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Coronavirus disease 2019 (COVID-19) in special groups: A single-center experience in sickle cell disease patients in Saudi Arabia - Transgenic News room	29.02.
SD Biosensor, Inc announced that it has received KRW 226.0893359 billion in funding from BioNote, Inc.	28.07.23
SD Biosensor, Inc announced that it expects to receive KRW 226.0893359 billion in funding from BioNote, Inc.	27.07.23
Columbus Holding Company announced that it has received KRW 258.2251644 billion in funding from SD Biosensor, Inc	28.06.23
Columbus Holding Company announced that it expects to receive KRW 258.2251644 billion in funding from SD Biosensor, Inc	13.06.23
SD Biosensor, Inc Reports Earnings Results for the First Quarter Ended March 31, 2023	15.05.23
SD Biosensor, Inc. Proposes Discontuation of Use and Disposal of Specific Pilot COVID-19 At-Home Tests in the United States Due to Microbial Contamination in the Liquid Disposal Solution	04.05.23
SD Biosensor, SJL Partners Acquire Meridian Bioscience	31.01.23
SD BioSensor, Inc and SJL Partners completed the acquisition of Meridian Bioscience, Inc. from Impactive Capital LP, BlackRock, Inc., The Vanguard Group, Inc, Royce & Associates, LP and others.	31.01.23
DoubleVerify Holdings to Replace Meridian Bioscience in S&P SmallCap 600	26.01.23
SD Biosensor Successfully Finishes JP Morgan Healthcare Conference 2023	13.01.23
Roche teams up with Pfizer on COVID-19 awareness campaign	14.12.22
Meridian Bioscience Says Closing Date of Pending Merger With SD Biosensor, Others Pushed Back to Jan. 31	12.12.22
Meridian Bioscience Fiscal Q4 Adjusted EPS, Revenue Decline	22.11.22
SD Biosensor Records 67% Jump in Q3 Profit; Shares Up 4%	04.11.22
Roche to introduce its next-generation portfolio of SARS-CoV-2 rapid antigen tests ("2.0") under CE Mark for self-test and professional use	12.10.22
Roche lancia una nuova generazione di test Covid in Europa	12.10.22
Roche lance une nouvelle génération de tests Covid en Europe	12.10.22
SD Biosensor to Supply $112.3 Million in COVID-19 Test Kits to Japan	19.08.22
South Korean Stocks Fall for Third Straight Day as Uncertainties Linger Around US Fed’s Rate Hikes Ahead; SD Biosensor Loses 2%	19.08.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen SD BioSensor, Inc

Aktien

A137310

KR7137310009

A137310

Andere Sprachen

Filter